Data from Israel in Health-Care Workers Vaccinated with 1st Dose of the Pfizer COVID-19 Vaccine

Background: Israel has succeeded in ramping up its vaccination program faster than any nation in the world. In December 2020, Israel began a national immunization campaign prioritizing health-care workers. In the original clinical trial data, the Pfizer vaccine was estimated to prevent 52.4% of COVID-19 before dose two and 90.5% on days 2 – 7 after dose two. However, it is important to study the effectiveness of the vaccines in a real world setting.

Paper: Amit S et al. Early Rate Reductions of SARS-CoV-2 Infection and COVID-19 in BNT162b2 Vaccine Recipients. Lancet 2021. PMID: 33610193 

Clinical Question: How effective is the Pfizer COVID-19 vaccine in decreasing viral transmission in health care workers with a single injection (i.e. prior to 14d post 2nd injection) of the Pfizer mRNA COVID-19 vaccine?

What They Did:

  • Analyzed a retrospective cohort of 9,109 vaccine-eligible health-care workers
  • Examined early reductions in SARS-Co-V-2 infection and COVID-19 rates in vaccinated health-care workers vs unvaccinated health care workers

Outcomes:

  • Positive SARS-CoV-2 PCR Infection
  • Symptomatic COVID-19

Inclusion:

  • All health-care workers

Exclusion:

  • Previous SARS-CoV-2 infection

Results:              

  • By Jan 24, 2021 of the 9,109 eligible staff:
    • 7,214 (79%) had received a 1st dose
    • 6037 (66%) had received a 2nd dose
  • Overall:
    • 170 SARS-CoV-2 infections of which 99 (58%) were symptomatic with COVID-19
      • 89 (52%) were unvaccinated
      • 78 (46%) were positive after the 1st dose
      • 3 (2%) tested positive after the 2nd dose
    • All SARS-CoV-2 Positive Rate in Vaccinated vs Unvaccinated:
      • Unvaccinated: 7.4/10,000 person-days
      • 1 – 14 days after 1st Dose: 5.5/10,000 person-days
        • Adjusted Rate Reductions of SARS-CoV-2 Infections Compared to Unvaccinated = 30% (95% CI 2 to 50)
      • 15 – 28 days after 1st Dose: 3.0/10,000 person-days
        • Adjusted Rate Reductions of SARS-CoV-2 Infections Compared to Unvaccinated = 75% (95% CI 72 to 84)
    • Symptomatic COVID-19 Rate in Vaccinated vs Unvaccinated:
      • Unvaccinated: 5.0/10,000 person-days
      • 1 – 14 days after 1st Dose: 2.8/10,000 person-days
        • Adjusted Rate Reductions of SARS-CoV-2 Infections Compared to Unvaccinated = 47% (95% CI 17 to 66)
      • 15 – 28 days after 1st Dose: 1.2/10,000 person-days
        • Adjusted Rate Reductions of SARS-CoV-2 Infections Compared to Unvaccinated = 85% (95% CI 71 to 92)

Clinical Take Home Point: This data from Israel on health-care workers that were vaccinated with the COVID-19 Pfizer vaccine shows a significant reduction in SARS-CoV-2 infection (asymptomatic) and symptomatic COVID-19 rates following the first vaccine dose, especially after the 15 to 28d post vaccination mark.

References:

  1. Amit S et al. Early Rate Reductions of SARS-CoV-2 Infection and COVID-19 in BNT162b2 Vaccine Recipients. Lancet 2021.

Post Peer Reviewed By: Anand Swaminathan, MD (Twitter: @EMSwami)

Cite this article as: Salim Rezaie, "Data from Israel in Health-Care Workers Vaccinated with 1st Dose of the Pfizer COVID-19 Vaccine", REBEL EM blog, March 28, 2021. Available at: https://rebelem.com/data-from-israel-in-health-care-workers-vaccinated-with-1st-dose-of-the-pfizer-covid-19-vaccine/.
The following two tabs change content below.

Salim Rezaie

Emergency Physician at Greater San Antonio Emergency Physicians (GSEP)
Creator & Founder of REBEL EM

Like this article?

Share on facebook
Share on Facebook
Share on twitter
Share on Twitter
Share on linkedin
Share on Linkdin
Share on email
Share via Email

Want to support rebelem?

Leave a Comment

Time limit is exhausted. Please reload CAPTCHA.

Sponsored

0